-+ 0.00%
-+ 0.00%
-+ 0.00%

Gain Therapeutics reports Phase 1b GT-02287 Parkinson’s data showing CSF DDC reduction at 90 days and stable MDS-UPDRS at day 150

Reuters·03/18/2026 12:15:24

Please log in to view news